[go: up one dir, main page]

TNSN01065A1 - Inhibiteur de nhe-1, et composition le contenant - Google Patents

Inhibiteur de nhe-1, et composition le contenant

Info

Publication number
TNSN01065A1
TNSN01065A1 TNTNSN01065A TNSN01065A TNSN01065A1 TN SN01065 A1 TNSN01065 A1 TN SN01065A1 TN TNSN01065 A TNTNSN01065 A TN TNSN01065A TN SN01065 A TNSN01065 A TN SN01065A TN SN01065 A1 TNSN01065 A1 TN SN01065A1
Authority
TN
Tunisia
Prior art keywords
composition containing
nhe
inhibitor
same
compound
Prior art date
Application number
TNTNSN01065A
Other languages
English (en)
Inventor
George Chen Weichao
David Cox Eric
Guzman-Perez Angel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN01065A1 publication Critical patent/TNSN01065A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L’INVENTION CONCERNE UN COMPOSE DE FORMULE 1 : ELLE CONCERNE EGALEMENT UNE COMPOSITION LE CONTENANT, APPLICATION : UTILISATION DE CE COMPOSE OU DE CETTE COMPOSITION POUR REDUIRE L'ALTERATION TISSULAIRE RESULTANT D'UNE ISCHEMIE.
TNTNSN01065A 2000-04-28 2001-04-27 Inhibiteur de nhe-1, et composition le contenant TNSN01065A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
TNSN01065A1 true TNSN01065A1 (fr) 2005-11-10

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01065A TNSN01065A1 (fr) 2000-04-28 2001-04-27 Inhibiteur de nhe-1, et composition le contenant

Country Status (40)

Country Link
EP (1) EP1276737A1 (fr)
JP (1) JP2003531900A (fr)
KR (1) KR20020093079A (fr)
CN (1) CN1225466C (fr)
AP (1) AP2002002651A0 (fr)
AR (1) AR028375A1 (fr)
AU (1) AU2001235896A1 (fr)
BG (1) BG107139A (fr)
BR (1) BR0110268A (fr)
CA (1) CA2407535A1 (fr)
CO (1) CO5221125A1 (fr)
CR (1) CR6797A (fr)
CZ (1) CZ20023408A3 (fr)
DZ (1) DZ3310A1 (fr)
EA (1) EA004882B1 (fr)
EE (1) EE200200615A (fr)
GT (1) GT200100064A (fr)
HN (1) HN2001000042A (fr)
HR (1) HRP20020851A2 (fr)
HU (1) HUP0300651A2 (fr)
IL (1) IL152075A0 (fr)
IS (2) IS6567A (fr)
MA (1) MA26897A1 (fr)
MX (1) MXPA02010600A (fr)
MY (1) MY133842A (fr)
NO (1) NO20025132L (fr)
NZ (1) NZ521348A (fr)
OA (1) OA12256A (fr)
PA (1) PA8513301A1 (fr)
PE (1) PE20011270A1 (fr)
PL (1) PL357765A1 (fr)
SK (1) SK14872002A3 (fr)
SV (1) SV2002000418A (fr)
TN (1) TNSN01065A1 (fr)
TR (1) TR200202439T2 (fr)
UA (1) UA73348C2 (fr)
UY (1) UY26680A1 (fr)
WO (1) WO2001083470A1 (fr)
YU (1) YU79602A (fr)
ZA (1) ZA200208605B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体１型阻害剤のエタノラート
JP2005511787A (ja) * 2001-12-19 2005-04-28 ファイザー・プロダクツ・インク ナトリウム−水素交換１型阻害物質を調製する方法
WO2003092694A1 (fr) * 2002-05-02 2003-11-13 Pfizer Products Inc. Traitement du diabete et de complications diabetiques a l'aide d'inhibiteurs nhe-1
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
CA2515939A1 (fr) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Nouveaux composes
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46200A (sh) * 1998-02-27 2003-02-28 Pfizer Products Inc. N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije

Also Published As

Publication number Publication date
NO20025132L (no) 2002-12-12
UY26680A1 (es) 2001-12-28
UA73348C2 (en) 2005-07-15
ZA200208605B (en) 2003-10-24
EP1276737A1 (fr) 2003-01-22
NZ521348A (en) 2004-09-24
IS6567A (is) 2002-09-24
NO20025132D0 (no) 2002-10-25
CR6797A (es) 2004-05-17
GT200100064A (es) 2002-03-22
AP2002002651A0 (en) 2002-12-31
PE20011270A1 (es) 2001-12-12
EA200201023A1 (ru) 2003-02-27
IL152075A0 (en) 2003-05-29
EE200200615A (et) 2004-04-15
WO2001083470A1 (fr) 2001-11-08
HUP0300651A2 (hu) 2003-07-28
CN1426404A (zh) 2003-06-25
PL357765A1 (en) 2004-07-26
EA004882B1 (ru) 2004-08-26
BG107139A (bg) 2003-07-31
SV2002000418A (es) 2002-07-03
MY133842A (en) 2007-11-30
KR20020093079A (ko) 2002-12-12
TR200202439T2 (tr) 2003-02-21
JP2003531900A (ja) 2003-10-28
BR0110268A (pt) 2003-12-30
SK14872002A3 (sk) 2004-03-02
IS6588A (is) 2002-10-21
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
CO5221125A1 (es) 2002-11-28
PA8513301A1 (es) 2003-09-05
AU2001235896A1 (en) 2001-11-12
CN1225466C (zh) 2005-11-02
CZ20023408A3 (cs) 2004-01-14
MXPA02010600A (es) 2003-03-10
AR028375A1 (es) 2003-05-07
OA12256A (en) 2003-11-06
HRP20020851A2 (en) 2005-02-28
HN2001000042A (es) 2001-07-09
DZ3310A1 (fr) 2001-11-07
CA2407535A1 (fr) 2001-11-08

Similar Documents

Publication Publication Date Title
TNSN02037A1 (fr) Sulfonylpyridazinones nouvelles inhibitrices d'aldose reductase et compositions les contenant
TNSN00191A1 (fr) Composes nouveaux, compositions les contenant et leur utilisation dans le traitement d'une ischemie
TNSN01145A1 (fr) Derives d'imidazole a noyau aryle ou heteroaryle condense, et compositions les contenant.
TNSN02015A1 (fr) Composes nouveaux antagonistes de ppar, et compositions les contenant
TNSN02008A1 (fr) Derives d'acides isophtalique nouveaux inhibiteurs de mmp, et compositions les contenant
BR0313420A (pt) Quinolonas microbicidas, suas composições e usos
TNSN02009A1 (fr) Pyrimidinones bicycliques condensees nouvelles, inhibitrices de mmp, et compositions les contenant.
TNSN02012A1 (fr) Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant
TNSN02010A1 (fr) Derives de pyrimidine nouveaux inhibiteurs de mmp, et compositions les contenant
EA200100412A1 (ru) Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
TNSN02011A1 (fr) Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MY136789A (en) Metalloproteinase inhibitors
DE60012188D1 (de) Fungizide
CA2430470A1 (fr) Nouvelle utilisation d'une classe de composes peptidiques pour traiter l'allodynie ou d'autres types de douleurs chroniques ou illusionnelles differentes
TNSN99001A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
BR9806752A (pt) Ftalazinonas.
ATE355284T1 (de) Inhibitoren von serinproteasen
NO20042534L (no) Forbedringer vedrorende optiske lysgjoringsmidler
BR0209149A (pt) Ftalazinonas
DE60126978D1 (de) Inhibitoren von serin proteasen
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
DE60117594D1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
TNSN01065A1 (fr) Inhibiteur de nhe-1, et composition le contenant
PL359763A1 (en) Fungicidal combinations of active agents